Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02086708 · ClinicalTrials.gov registry record · NA
Ultrasound Method to Measure Fibrosis of the Liver in Children
A NA study, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02086708: Clinical Trial NA study, sponsored by Massachusetts General Hospital.
NCT02086708 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02086708, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
HYPOTHESIS: The investigators hypothesize that sonoelastography (SE) provide accurate quantitative measurements that can be used to stage liver fibrosis in pediatric patients with chronic liver disease. Specific Aims: To measure liver stiffness with sonoelastography in pediatric and adolescents with suspect diffuse liver disease who will undergo nonfocal liver biopsy as part of their routine clinical care.
Interventions
- DEVICE Shear Wave sonoelastography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-06 |
| Est. Completion | 2015-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02086708
The ClinicalTrials.gov registry entry for NCT02086708 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Shear Wave sonoelastography is the first listed.
NCT02086708 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02086708 about?
NCT02086708 is a clinical study titled "Ultrasound Method to Measure Fibrosis of the Liver in Children". HYPOTHESIS: The investigators hypothesize that sonoelastography (SE) provide accurate quantitative measurements that can be used to stage liver fibrosis in pediatric patients with chronic liver disease. Specific Aims: To measure liver stiffness with sonoelastography in pediatric and adolescents wi...
What is the current status of trial NCT02086708?
This trial is currently terminated. It is a NA study. The enrollment target is 24 participants. The study started on 2010-06. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02086708?
The interventions under investigation include: Shear Wave sonoelastography (DEVICE).
Who is sponsoring clinical trial NCT02086708?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.